-
1
-
-
24944534960
-
Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
-
Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-5650
-
(2005)
J Clin Oncol
, vol.23
, pp. 5644-5650
-
-
Folkesson, J.1
Birgisson, H.2
Pahlman, L.3
Cedermark, B.4
Glimelius, B.5
Gunnarsson, U.6
-
2
-
-
0033062893
-
p53 status: An indicator for the effect of preoperative radiotherapy of rectal cancer
-
Adell G, Sun XF, Stål O, Klintenberg C, Sjödahl R, Nordenskjöld B. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 1999; 51: 169-174
-
(1999)
Radiother Oncol
, vol.51
, pp. 169-174
-
-
Adell, G.1
Sun, X.F.2
Stål, O.3
Klintenberg, C.4
Sjödahl, R.5
Nordenskjöld, B.6
-
3
-
-
33748433241
-
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
-
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223
-
(2006)
Br J Surg
, vol.93
, pp. 1215-1223
-
-
Bujko, K.1
Nowacki, M.P.2
Nasierowska-Guttmejer, A.3
Michalski, W.4
Bebenek, M.5
Kryj, M.6
-
4
-
-
33751271180
-
Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: Radiotherapy is redundant in intrinsically high-apoptotic tumors
-
de Bruin EC, van de Velde CJ, van de Pas S, Nagtegaal ID, van Krieken JH, Gosens MJ, Peltenburg LT, Medema JP, Marijnen CA. Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res 2006; 12: 6432-6436
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6432-6436
-
-
de Bruin, E.C.1
van de Velde, C.J.2
van de Pas, S.3
Nagtegaal, I.D.4
van Krieken, J.H.5
Gosens, M.J.6
Peltenburg, L.T.7
Medema, J.P.8
Marijnen, C.A.9
-
5
-
-
0035873139
-
Apoptosis in rectal carcinoma: Prognosis and recurrence after preoperative radiotherapy
-
Adell GC, Zhang H, Evertsson S, Sun XF, Stål OH, Nordenskjöld BA. Apoptosis in rectal carcinoma: prognosis and recurrence after preoperative radiotherapy. Cancer 2001; 91: 1870-1875
-
(2001)
Cancer
, vol.91
, pp. 1870-1875
-
-
Adell, G.C.1
Zhang, H.2
Evertsson, S.3
Sun, X.F.4
Stål, O.H.5
Nordenskjöld, B.A.6
-
6
-
-
0033812746
-
Apoptosis in rectal cancer: Prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables
-
Schwandner O, Schiedeck TH, Bruch HP, Duchrow M, Windhoevel U, Broll R. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables. Dis Colon Rectum 2000; 43: 1227-1236
-
(2000)
Dis Colon Rectum
, vol.43
, pp. 1227-1236
-
-
Schwandner, O.1
Schiedeck, T.H.2
Bruch, H.P.3
Duchrow, M.4
Windhoevel, U.5
Broll, R.6
-
7
-
-
0034998192
-
Caspase-3 activity as a prognostic factor in colorectal carcinoma
-
Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 2001; 81: 681-688
-
(2001)
Lab Invest
, vol.81
, pp. 681-688
-
-
Jonges, L.E.1
Nagelkerke, J.F.2
Ensink, N.G.3
van der Velde, E.A.4
Tollenaar, R.A.5
Fleuren, G.J.6
van de Velde, C.J.7
Morreau, H.8
Kuppen, P.J.9
-
8
-
-
0035145738
-
Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but antisense SAG transfection inhibits tumor cell growth
-
Huang Y, Duan H, Sun Y. Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but antisense SAG transfection inhibits tumor cell growth. Mol Carcinog 2001; 30: 62-70
-
(2001)
Mol Carcinog
, vol.30
, pp. 62-70
-
-
Huang, Y.1
Duan, H.2
Sun, Y.3
-
9
-
-
0035923305
-
Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer
-
Sasaki H, Yukiue H, Kobayashi Y, Moriyama S, Nakashima Y, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y. Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer. Int J Cancer 2001; 95: 375-377
-
(2001)
Int J Cancer
, vol.95
, pp. 375-377
-
-
Sasaki, H.1
Yukiue, H.2
Kobayashi, Y.3
Moriyama, S.4
Nakashima, Y.5
Kaji, M.6
Fukai, I.7
Kiriyama, M.8
Yamakawa, Y.9
Fujii, Y.10
-
10
-
-
0003001202
-
American Joint Committee on Cancer (AJCC)
-
5th ed. Philadelphia: J.B. Lippincott
-
Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, Kennedy BJ, Murphy GP, O'Sullivan BO, Sobin LH, Yarbro JW. American Joint Committee on Cancer (AJCC). In: AJCC cancer staging manual. 5th ed. Philadelphia: J.B. Lippincott, 1997
-
(1997)
AJCC Cancer Staging Manual
-
-
Fleming, I.D.1
Cooper, J.S.2
Henson, D.E.3
Hutter, R.V.P.4
Kennedy, B.J.5
Murphy, G.P.6
Kennedy, B.J.7
Murphy, G.P.8
O'Sullivan, B.O.9
Sobin, L.H.10
Yarbro, J.W.11
-
11
-
-
0036134525
-
Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil
-
Nozue M, Isaka N, Maruyama T, Kawamoto T, Seino KI, Tanagichi H, Fukao K. Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil. Oncol Rep 2002; 9: 93-96
-
(2002)
Oncol Rep
, vol.9
, pp. 93-96
-
-
Nozue, M.1
Isaka, N.2
Maruyama, T.3
Kawamoto, T.4
Seino, K.I.5
Tanagichi, H.6
Fukao, K.7
-
12
-
-
0035727107
-
Chemotherapy practice patterns for colorectal cancer patients in 1998: A survey of Canadian oncologist
-
Ng E, Maroun J, Berthelot J-M, Dahrouge S. Chemotherapy practice patterns for colorectal cancer patients in 1998: A survey of Canadian oncologist. Current Oncology 2001; 8: 150-158
-
(2001)
Current Oncology
, vol.8
, pp. 150-158
-
-
Ng, E.1
Maroun, J.2
Berthelot, J.-M.3
Dahrouge, S.4
-
13
-
-
0036471058
-
Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer
-
Rödel C, Grabenbauer GG, Papadopoulos T, Bigalke M, Günther K, Schick C, Peters A, Sauer R, Rödel F. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52: 294-303
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 294-303
-
-
Rödel, C.1
Grabenbauer, G.G.2
Papadopoulos, T.3
Bigalke, M.4
Günther, K.5
Schick, C.6
Peters, A.7
Sauer, R.8
Rödel, F.9
-
14
-
-
0034744271
-
P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer
-
Esposito G, Pucciarelli S, Alaggio R, Giacomelli L, Marchiori E, Iaderosa GA, Friso ML, Toppan P, Chieco-Bianchi L, Lise M. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol 2001; 8: 311-318
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 311-318
-
-
Esposito, G.1
Pucciarelli, S.2
Alaggio, R.3
Giacomelli, L.4
Marchiori, E.5
Iaderosa, G.A.6
Friso, M.L.7
Toppan, P.8
Chieco-Bianchi, L.9
Lise, M.10
-
15
-
-
3042661957
-
Role of cell cycle in mediating sensitivity to radiotherapy
-
Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 928-942
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 928-942
-
-
Pawlik, T.M.1
Keyomarsi, K.2
-
16
-
-
0035143141
-
Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: Association with inhibition of p27 accumulation
-
Duan H, Tsvetkov LM, Liu Y, Song Y, Swaroop M, Wen R, Kung HF, Zhang H, Sun Y. Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation. Mol Carcinog 2001; 30: 37-46
-
(2001)
Mol Carcinog
, vol.30
, pp. 37-46
-
-
Duan, H.1
Tsvetkov, L.M.2
Liu, Y.3
Song, Y.4
Swaroop, M.5
Wen, R.6
Kung, H.F.7
Zhang, H.8
Sun, Y.9
-
17
-
-
34548846689
-
SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB
-
Gu Q, Bowden GT, Normolle D, Sun Y. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. J Cell Biol 2007; 178: 1009-1023
-
(2007)
J Cell Biol
, vol.178
, pp. 1009-1023
-
-
Gu, Q.1
Bowden, G.T.2
Normolle, D.3
Sun, Y.4
-
18
-
-
0029787506
-
Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL
-
Simonian PL, Grillot DA, Merino R, Nuñez G. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. J Biol Chem 1996; 271: 22764-22772
-
(1996)
J Biol Chem
, vol.271
, pp. 22764-22772
-
-
Simonian, P.L.1
Grillot, D.A.2
Merino, R.3
Nuñez, G.4
-
19
-
-
0025751550
-
Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
-
Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-888
-
(1991)
Cell
, vol.67
, pp. 879-888
-
-
Sentman, C.L.1
Shutter, J.R.2
Hockenbery, D.3
Kanagawa, O.4
Korsmeyer, S.J.5
-
20
-
-
0025786164
-
Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
-
Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889-899
-
(1991)
Cell
, vol.67
, pp. 889-899
-
-
Strasser, A.1
Harris, A.W.2
Cory, S.3
-
22
-
-
0032422475
-
Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer
-
Maurer CA, Friess H, Bühler SS, Wahl BR, Graber H, Zimmermann A, Büchler MW. Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer. Dig Dis Sci 1998; 43: 2641-2648
-
(1998)
Dig Dis Sci
, vol.43
, pp. 2641-2648
-
-
Maurer, C.A.1
Friess, H.2
Bühler, S.S.3
Wahl, B.R.4
Graber, H.5
Zimmermann, A.6
Büchler, M.W.7
-
23
-
-
0029945789
-
Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas
-
Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56: 2422-2427
-
(1996)
Cancer Res
, vol.56
, pp. 2422-2427
-
-
Krajewska, M.1
Moss, S.F.2
Krajewski, S.3
Song, K.4
Holt, P.R.5
Reed, J.C.6
-
24
-
-
0034851759
-
Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas
-
Wolf HK, Stöber C, Hohenfellner R, Leissner J. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas. Tumour Biol 2001; 22: 328-336
-
(2001)
Tumour Biol
, vol.22
, pp. 328-336
-
-
Wolf, H.K.1
Stöber, C.2
Hohenfellner, R.3
Leissner, J.4
-
25
-
-
0017138673
-
Current status of treatment in storage disorders
-
Nadler HL. Current status of treatment in storage disorders. Birth Defects Orig Artic Ser 1976; 12: 177-188
-
(1976)
Birth Defects Orig Artic Ser
, vol.12
, pp. 177-188
-
-
Nadler, H.L.1
|